Doximity (NYSE:DOCS) Director Sells $65,780.00 in Stock

Doximity, Inc. (NYSE:DOCS) Director Kira Wampler sold 2,000 shares of the company’s stock in a transaction dated Monday, November 2nd. The stock was sold at an average price of $32.89, for a total value of $65,780.00. Following the completion of the transaction, the director directly owned 27,923 shares of the company’s stock, valued at $918,387.47. The trade was a 6.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Kira Scherer Wampler also recently made the following trade(s):

• On Thursday, October 1st, Kira Wampler sold 2,000 shares of Doximity stock. The shares were sold at an average price of $28.91, for a total value of $57,820.00.
• On Tuesday, August 25th, Kira Wampler sold 2,000 shares of Doximity stock. The shares were sold at an average price of $24.95, for a total value of $49,900.00.

Doximity Stock Performance

DOCS opened at $32.51 on Friday. The business’s fifty day moving average is $29.09 and its 200-day moving average is $25.51. The firm has a market cap of $5.79 billion, a P/E ratio of 45.15, a price-to-earnings-growth ratio of 25.71 and a beta of 1.29. Doximity, Inc. has a 52-week low of $17.15 and a 52-week high of $58.24.

Doximity (NYSE:DOCS) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.16 by $0.13. The company had revenue of $156.62 million during the quarter. Doximity had a return on equity of 18.06% and a net margin of 25.48%. Doximity’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.36 earnings per share. On average, research analysts predict that Doximity, Inc. will post 0.74 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on DOCS. Truist Financial upped their price target on shares of Doximity from $19.00 to $24.00 and gave the company a “hold” rating in a research note on Thursday, August 13th. Royal Bank Of Canada lifted their target price on Doximity from $28.00 to $34.00 and gave the company an “outperform” rating in a report on Friday. Zacks Research raised shares of Doximity from a “strong sell” rating to a “hold” rating in a report on Monday, July 13th. Piper Sandler restated an “overweight” rating and set a $47.00 price target (up from $42.00) on shares of Doximity in a research report on Friday, August 7th. Finally, Wells Fargo & Company lowered shares of Doximity from an “equal weight” rating to an “underweight” rating and set a $18.00 price target for the company. in a report on Monday, August 10th. Eight investment analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Doximity currently has a consensus rating of “Hold” and an average price target of $30.45.

Institutional Trading of Doximity

Several institutional investors have recently added to or reduced their stakes in DOCS. Carmignac Gestion lifted its position in shares of Doximity by 127.8% during the 1st quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock valued at $100,480,000 after buying an additional 2,418,971 shares during the last quarter. Wellington Management Group LLP raised its holdings in Doximity by 24.7% in the 2nd quarter. Wellington Management Group LLP now owns 3,135,113 shares of the company’s stock valued at $65,022,000 after acquiring an additional 621,464 shares during the last quarter. Quantinno Capital Management LP increased its holdings in shares of Doximity by 420.5% in the 1st quarter. Quantinno Capital Management LP now owns 140,345 shares of the company’s stock valued at $3,270,000 after acquiring an additional 113,380 shares during the last quarter. Royal Bank of Canada lifted its holdings in shares of Doximity by 28.4% in the first quarter. Royal Bank of Canada now owns 206,282 shares of the company’s stock valued at $4,806,000 after purchasing an additional 45,618 shares in the last quarter. Finally, Assenagon Asset Management S.A. purchased a new stake in shares of Doximity during the third quarter worth about $28,858,000. 87.19% of the stock is currently owned by institutional investors.

Trending Headlines about Doximity

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Fiscal Q2 revenue was $174.5 million, ahead of the $170.8 million FactSet estimate, while adjusted earnings were $0.36 per share versus the $0.34 Zacks consensus. Revenue grew 3.6% year over year. Doximity beats Q2 earnings and revenue estimates
• Positive Sentiment: Management forecast fiscal Q3 revenue of $195–196 million and FY2027 revenue of $678–683 million, both above analysts’ estimates. The company also cited record engagement, more than 190 health systems purchasing its AI suite, and a 51% adjusted EBITDA margin. Doximity fiscal 2027 second-quarter results
• Positive Sentiment: Canaccord raised its price target to $40 with a Buy rating, RBC lifted its target to $34 and maintained Outperform, and Needham reaffirmed Buy with a $41 target. These revisions signal continued analyst support. Canaccord analyst recommendations
• Neutral Sentiment: AI products are expanding, but an earnings deep-dive framed that growth against margin-compression concerns. Investors may focus on whether AI-related investment can translate into durable revenue and profitability. AI-driven product expansion meets margin compression
• Negative Sentiment: Multiple law firms publicized a securities class action and the November 16 lead-plaintiff deadline for investors who bought shares between August 8, 2024 and May 13, 2026. The suit includes allegations concerning Newsfeed revenue and growth; these claims have not been established in court. The litigation adds uncertainty. Class-action lead plaintiff deadline notice

About Doximity

Doximity, Inc operates a digital platform designed for medical professionals in the United States. Its network connects physicians, nurse practitioners, physician assistants, pharmacists and other healthcare professionals, providing tools for professional communication, collaboration and career development.

The company offers services including secure messaging, telehealth, digital faxing, physician scheduling and professional networking. Doximity also provides medical news and educational content, as well as recruiting and job-search resources for healthcare professionals.

Doximity generates additional revenue through digital marketing and engagement solutions for pharmaceutical companies, healthcare organizations and health systems.